Harbor Capital Advisors Inc. Grows Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Harbor Capital Advisors Inc. boosted its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 65.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 157,671 shares of the company's stock after acquiring an additional 62,320 shares during the period. Harbor Capital Advisors Inc. owned about 0.08% of Cellebrite DI worth $3,473,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Telemark Asset Management LLC purchased a new position in Cellebrite DI in the third quarter valued at approximately $6,736,000. Two Sigma Advisers LP boosted its holdings in shares of Cellebrite DI by 9.8% in the 3rd quarter. Two Sigma Advisers LP now owns 1,341,100 shares of the company's stock valued at $22,584,000 after buying an additional 120,000 shares in the last quarter. Scalar Gauge Management LLC grew its position in shares of Cellebrite DI by 15.2% in the 2nd quarter. Scalar Gauge Management LLC now owns 453,554 shares of the company's stock valued at $5,420,000 after buying an additional 60,000 shares during the last quarter. Connors Investor Services Inc. acquired a new stake in Cellebrite DI during the 2nd quarter worth $1,803,000. Finally, State Street Corp raised its stake in Cellebrite DI by 7.3% during the 3rd quarter. State Street Corp now owns 443,700 shares of the company's stock worth $7,472,000 after acquiring an additional 30,052 shares in the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CLBT has been the topic of several research reports. TD Cowen raised their price objective on Cellebrite DI from $20.00 to $23.00 and gave the stock a "buy" rating in a report on Monday, September 23rd. Craig Hallum raised their price target on Cellebrite DI from $23.00 to $24.00 and gave the stock a "buy" rating in a research note on Thursday, November 7th. Needham & Company LLC boosted their price objective on Cellebrite DI from $17.00 to $21.00 and gave the company a "buy" rating in a research note on Thursday, November 7th. Finally, JPMorgan Chase & Co. increased their price objective on Cellebrite DI from $22.00 to $24.00 and gave the company an "overweight" rating in a report on Monday, December 16th. Eight research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Cellebrite DI has a consensus rating of "Buy" and a consensus target price of $20.57.

Cellebrite DI Trading Down 1.2 %

Shares of Cellebrite DI stock traded down $0.26 during trading hours on Friday, hitting $21.57. 1,587,294 shares of the company were exchanged, compared to its average volume of 988,114. The business has a 50-day moving average of $20.39 and a 200-day moving average of $17.23. Cellebrite DI Ltd. has a 1 year low of $7.91 and a 1 year high of $22.91. The stock has a market capitalization of $4.44 billion, a price-to-earnings ratio of -13.92, a P/E/G ratio of 2.71 and a beta of 1.46.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. The company had revenue of $106.90 million during the quarter, compared to analysts' expectations of $102.06 million. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business's revenue was up 27.0% on a year-over-year basis. During the same quarter last year, the business earned $0.09 EPS. As a group, research analysts anticipate that Cellebrite DI Ltd. will post 0.32 earnings per share for the current fiscal year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.